Glycobiology Advance Access originally published online on November 10, 2005
Glycobiology 2006 16(3):184-196; doi:10.1093/glycob/cwj055
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
A monoclonal antibody against a carbohydrate epitope in lipopolysaccharide differentiates Chlamydophila psittaci from Chlamydophila pecorum, Chlamydophila pneumoniae, and Chlamydia trachomatis
3 Research Center Borstel, Leibniz Center for Medicine and Biosciences, Parkallee 22, D-23845 Borstel, Germany; 4 Institute for Biological Sciences, National Research Council Canada, Ottawa, Ontario, Canada K1A 0R6; and 5 Department of Chemistry, University of Natural Resources and Applied Life Sciences, A-1190 Vienna, Austria
1 These authors contributed equally to this work.
2 To whom correspondence should be addressed; e-mail: hebra{at}fz-borstel.de
Received on August 9, 2005; revised on November 2, 2005; accepted on November 3, 2005
Lipopolysaccharide (LPS) of Chlamydophila psittaci but not of Chlamydophila pneumoniae or Chlamydia trachomatis contains a tetrasaccharide of 3-deoxy-
-D-manno-oct-2-ulopyranosonic acid (Kdo) of the sequence Kdo(2
8)[Kdo(24)] Kdo(24)Kdo. After immunization with the synthetic neoglycoconjugate antigen Kdo(28)[Kdo(24)]Kdo(24) Kdo-BSA, we obtained the mouse monoclonal antibody (mAb) S69-4 which was able to differentiate C. psittaci from Chlamydophila pecorum, C. pneumoniae, and C. trachomatis in double labeling experiments of infected cell monolayers and by enzyme-linked immunosorbent assay (ELISA). The epitope specificity of mAb S69-4 was determined by binding and inhibition assays using bacteria, LPS, and natural or synthetic Kdo oligosaccharides as free ligands or conjugated to BSA. The mAb bound preferentially Kdo(28)[Kdo(24)]Kdo(24)Kdo(24) with a Kd of 10 µM, as determined by surface plasmon resonance (SPR) for the monovalent interaction using mAb or single chain Fv. Cross-reactivity was observed with Kdo(24)Kdo(24) Kdo but not with Kdo(28)Kdo(24)Kdo, Kdo disaccharides in 24- or 28-linkage, or Kdo monosaccharide. MAb S69-4 was able to detect LPS on thin-layer chromatography (TLC) plates in amounts of <10 ng by immunostaining. Due to the high sensitivity achieved in this assay, the antibody also detected in vitro products of cloned Kdo transferases of Chlamydia. The antibody can therefore be used in medical and veterinarian diagnostics, general microbiology, analytical biochemistry, and studies of chlamydial LPS biosynthesis. Further contribution to the general understanding of carbohydrate-binding antibodies was obtained by a comparison of the primary structure of mAb S69-4 to that of mAb S45-18 of which the crystal structure in complex with its ligand has been elucidated recently (Nguyen et al., 2003, Nat. Struct. Biol., 10, 1019–1025).
Key words: diagnostic / immunofluorescence / Kdo / neoglycoconjugate
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. L Brooks, R. J Blackler, G. Sixta, P. Kosma, S. Muller-Loennies, L. Brade, T. Hirama, C R. MacKenzie, H. Brade, and S. V Evans The role of CDR H3 in antibody recognition of a synthetic analog of a lipopolysaccharide antigen Glycobiology, February 1, 2010; 20(2): 138 - 147. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Klein, B. Lindner, W. Brabetz, H. Brade, and S. Raina Escherichia coli K-12 Suppressor-free Mutants Lacking Early Glycosyltransferases and Late Acyltransferases: MINIMAL LIPOPOLYSACCHARIDE STRUCTURE AND INDUCTION OF ENVELOPE STRESS RESPONSE J. Biol. Chem., June 5, 2009; 284(23): 15369 - 15389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Rapaka, E. S. Goetzman, M. Zheng, J. Vockley, L. McKinley, J. K. Kolls, and C. Steele Enhanced Defense against Pneumocystis carinii Mediated by a Novel Dectin-1 Receptor Fc Fusion Protein J. Immunol., March 15, 2007; 178(6): 3702 - 3712. [Abstract] [Full Text] [PDF]
|
|